Series B Momentum Hilo has just closed a $19M Series B extension bringing total funding to over $119M, signaling strong investor confidence and potential readiness for enterprise-grade partnerships and larger pilot programs with health systems and insurers.

Global Expansion Headquartered in Switzerland with active global expansion and a U.S. launch of Hilo Core, presenting opportunities to partner with international healthcare providers, distributors, and cross-border SaaS integrations.

Data & AI Advantage Aktiia's foundation model trained on billions of optical signals and hundreds of millions of readings offers a highly differentiated AI-enabled CI/CD data platform, ideal for partnerships with wearables ecosystems, EHRs, and telehealth platforms seeking continuous BP insights.

Product Diversification Recent launches such as Hilo Core and the Blood Pressure health system indicate a pivot toward long-term BP insights and pattern recognition, creating cross-sell opportunities for device hardware, software subscriptions, and clinician-facing analytics.

Security & Risk Ransomware incident flagged in mid-2026 underscores the need for stronger security offerings; a joint sales angle could emphasize enhanced cybersecurity integrations, compliant data handling, and resilience features to reassure enterprise customers.